Clinical Trial Details

Overview

Research Study Summary

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

Purpose

Doctors are testing the safety, effectiveness and tolerability of an oral investigational medication to determine if it helps control the symptoms of social anxiety disorder.

Participants will receive the study drug and all study-related care at no cost.

xjung@ptrg.com.au

To Learn more

CW ID: 226381
Date Last Changed: September 27, 2017

Clinical Trial Snapshot

Phase
2
Gender
Both Male and Female
Age
18 to 64 Years
Overall Status
Recruiting
Duration
20 Weeks
Facility Type
Out-Patient

Eligibility

Inclusion:
  • Diagnosed with Social Anxiety Disorder
  • Are 18 - 64 years of age
  • Females must be of non-childbearing potential
Exclusion:
  • Has performance only social anxiety.
  • Is currently receiving psychotherapy.

More Info

Study participation involves a screening visit followed by a 12 week treatment period and a follow-up visit between one to four weeks after you take the final dose. You cannot take psychotropic medications such as mood stabilizers or anti-anxiety medications during the study.

For more information, please email us at: jnj.ct@sylogent.com

Contact

xjung@ptrg.com.au

Xenia Jung
Peninsula Therapeutic and Research Group
Located in
Frankston 3199
Australia
Phone: 03 9770 1579

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.